Why GLP-1 raw material attracts clone sites
GLP-1 raw material is the most copied category in research-peptide supply for a plain reason: demand is high, the molecules are expensive to make properly, and a buyer cannot tell a correct vial from a wrong one by looking at it. Semaglutide, tirzepatide, retatrutide and the newer dual and triple agonists all arrive as white lyophilized powder in a sealed vial, and nothing about the powder says whether it is a 39-residue acylated peptide at the stated purity or something else.
That gap creates room for clone sites. A clone makes nothing. It copies a real manufacturer's facility photos, product images, lot numbers and sometimes whole lab reports, puts them under a new brand name on a new domain, and collects payment. Copying costs almost nothing, which is why one photo set can appear under several brand names at once.
What a clone cannot copy
The useful question is not whether a site looks real but what a clone finds hard to fake. It cannot publish months of its own batch records on its own domain, because it has no batches. It cannot keep a lot alias consistent from quote to certificate to carton label to dispatch photo, because it does not handle the carton. And it cannot make a sample test right at a laboratory you chose. Every step below targets one of those weak points.
Check the entity: one name, one address, one domain, one number
Start with the entity, not the product page. A manufacturer has a place where it makes material, and it will say where. Look for an operating name, a site address, an email on a domain the business controls, and a WhatsApp identity, and check that each is used the same way on every page, on the quote and on the certificate header.
Pepti is the example this site can show in full. The material on peptiglp1.com is manufactured by Pepti, Guangzhou, at a stated address in Baiyun District; the batch records are published on the parent domain, peptioem.com; the contact email is on that domain; and the WhatsApp contact is a single identity reached through the Pepti-RFQ button. A brand site with a parent domain is not a warning sign in itself, as long as the relationship is declared rather than left for you to infer.
Checks that take minutes
- Address. A physical site, not a mailbox or a trading-company suite, matching the address the parent domain gives. Put it into a map; an industrial street in a manufacturing district is what you expect to see.
- Email domain. Quotes and certificates should come from the business domain. A free webmail address on a quote is the most common tell of a clone, because a domain mailbox is exactly the step a copier skips.
- WhatsApp identity. Message the number published on the site and ask it to confirm the quote you received. A quote from a different number means more than one entity, and at most one of them is the manufacturer.
- Photo provenance. Reverse-image-search the facility and product photos. The same set under several brand names is a clone cluster; the original is usually the domain hosting the complete batch-record library, but treat that as a lead, not proof.
Open a batch record and read it like a QC chemist
A public batch record is the first document that separates a manufacturer from a copier: cheap to publish, nearly impossible to fabricate at scale with internal consistency. Open one now: PEP260819-RT20, a retatrutide 20 mg lot, manufactured 2026-08-19, tested 2026-08-22, HPLC result 99.26%.
Fields that must be present
A lot-specific record names the compound, carries a lot alias, states the nominal strength per vial, gives a manufacture date and a separate test date, and reports RP-HPLC purity as a figure, not a range. The released certificate behind it adds MS identity: the observed mass against the theoretical mass of the free peptide, close to 4731 g/mol for retatrutide, 4813 g/mol for tirzepatide and 4114 g/mol for semaglutide. If any field is missing, you are looking at a product sheet, not a batch record.
Template or lot-specific?
The lot alias is the quickest test. Pepti's aliases encode product and manufacture date: PEP260819-RT20 is retatrutide, 20 mg, made on 2026-08-19, so the manufactured date on the record must agree with the digits in the alias, and the test date must fall after it; here it is 2026-08-22. A template fails in obvious ways: no alias, an alias that does not change between products, dates identical across every record, or no dates at all.
The purity figures are the other test. Across the public library, 76 entries as checked on 2026-10-19, semaglutide lots run 98.7%–99.6% across 7 records, tirzepatide 98.4%–99.7% across 9, and retatrutide 98.72%–99.55% across 9. Real lots vary inside a band like that; a site printing one identical figure for every compound and strength has no data behind it.
Cross-check with PEP260722-TR30 (tirzepatide 30 mg, 99.7%, made 2026-07-22, tested 2026-07-29) and PEP260718-SM20 (semaglutide 20 mg, 99.6%, made 2026-07-18, tested 2026-07-28): different aliases, dates and results, one format. The quality page explains how each record gets there.
Follow the lot alias from quote to carton
A record on a website proves the supplier has lots, not that the vials you receive come from one of them. That proof is a chain of documents, each carrying the same lot alias; ask for each link in writing and compare the alias character by character.
- Quote or order confirmation. For a listed compound in stock, the alias can be named before you pay. For material made to order, it is assigned at manufacture; the confirmation should say so and commit to naming it before dispatch.
- Certificate. The alias must resolve to a record on the supplier's own domain, in the same format as the rest of the library. A PDF with no web record, or a record on a domain the supplier does not control, breaks the chain.
- Carton label. Ask for a photograph of the labeled inner carton before it leaves the site. Alias, compound and strength must match the certificate.
- Dispatch photograph. The packed shipment with courier label and carton visible closes the loop. Pepti publishes these by month and destination on the order-photos page, so you can see the format before you order.
If any link is missing, ask for it once, plainly. A manufacturer can produce a carton photo on request because the carton is in its own building; a clone has to ask someone else, and that delay, or a different alias, is your answer. Do not pay the balance, and do not scale, until the chain is complete.
Test a received sample at a laboratory you choose
With the documents checked, the last step is the material itself, and it is the one a clone cannot pass. Order 1 kit (10 vials), receive it at your own premises, and send part of it to an analytical laboratory that you selected and pay directly. Do not let the supplier ship to the lab for you; a chain of custody that starts at your door is the point.
What panel to ask for
- RP-HPLC purity. Area-percent of the main peak against all peptide-related peaks. Ask for the chromatogram, not just the figure, so you can compare the impurity pattern with the release chromatogram the supplier can share for the lot.
- MS identity. Observed mass against the theoretical value, with the charge states used (z = 3, 4, 5 are typical), and the common modifications flagged: +16 Da oxidation, +1 Da deamidation, −18 Da water loss.
- Net content. Peptide per vial, measured against a reference standard and reported in mg. Content and purity are different questions: a vial can be pure and under-filled, or full and impure.
A verifiable example: Janoshik Analytical report #210105 covers a Pepti retatrutide 20 mg sample, analyzed 2026-10-07, and reports 19.52 mg content and 99.837% purity. Anyone with the link can check it at verify.janoshik.com. It is a sample-specific result for one submitted vial, not a claim about any other product or lot, and Pepti does not present it as one.
When a supplier forwards a lab report, open the lab's verification page yourself and read the client field before the purity: the lab prints the name of whoever submitted the sample, which is why a copied report so often names someone else.
Practical tip. Write your acceptance criteria into the purchase order before the sample ships: identity by MS, purity within the band the supplier's own public records show for that compound, content close to the nominal strength. A criterion written down afterwards is an argument; one written down beforehand is a decision.
Red flags that end the conversation
Most clone sites fail early in this routine, but some are careful. Any one sign below is enough to pause; several together are enough to stop.
| Red flag | What it usually means | What to do |
|---|---|---|
| Generic certificate with no lot alias | A template; there may be no batch behind it | Ask for the alias and record URL of the lot you will receive |
| Lab report naming another client | The report was copied from a different business | Open the lab's verification page; if the client is not the supplier, stop |
| Purity claimed on the homepage, no record behind it | A marketing figure | Ask which lot the figure comes from; no answer means no data |
| Pressure to pay fast | The seller wants the wire to land before you finish checking | Finish the routine; a manufacturer with stock loses nothing by waiting |
| No stated operating address | Nowhere to make the material and nowhere to be found | Ask for the site address; if the answer is a mailbox, stop |
| Several brand names sharing one photo set | A clone cluster built on one copied set of images | Verify only the domain that hosts the batch records |
| Refuses a 1-kit sample order | No material to ship, or no interest in being tested | Do not place a larger order with a supplier that refuses sampling |
What a research-use manufacturer can show, and what it must not claim
Knowing what an honest research-use manufacturer can put in front of you also tells you which claims should make you suspicious: a seller promising more than the category allows is either careless or copying.
What can be shown
- A lot-specific certificate reporting RP-HPLC purity and MS identity, with a record on the manufacturer's own domain, and a public library of such records with its entry count and last-checked date stated.
- The release chromatogram for a lot on request, so your lab can compare impurity patterns.
- Dispatch photographs, a stated site address, and a willingness to be sampled with 1 kit (10 vials).
- An independent laboratory report with the lab's own verification link, presented as sample-specific.
- Storage conditions printed on the certificate; in this category the commonly used conditions are −20 °C for sealed lyophilized powder and 2–8 °C for short holding.
- Lead times as typical ranges: sample kits typically 5–10 days, a production batch typically 14–21 days, an OEM repeat order typically 21–28 days, each confirmed on the RFQ rather than promised.
What must not be claimed
A research-use manufacturer must not describe the material as suitable for any use in people or animals, must not claim a regulatory status it does not hold, and must not quote a fixed delivery date as a term of the contract. For research use only. Not for human or veterinary use. If a seller offers more than this, the extra promise is itself the red flag.
Pepti does not present itself as a cGMP drug-substance (API) manufacturer or CDMO and does not publish a GMP certificate or DMF. What it does publish, lot by lot, is described on the quality page.
A sample order as the qualification step
Run the steps as one protocol for every new supplier and every new compound, with the sample order as the qualification gate, so the money at risk is the cost of 1 kit rather than a production batch.
- Entity check. Record operating name, site address, email domain and WhatsApp identity, and confirm they match across pages and on the quote.
- Record check. Open a public batch record for the compound, decode the alias, and check the dates and the purity figure against the published band.
- Order 1 kit (10 vials). Ask for the lot alias in writing before dispatch, with the record URL, carton photo and dispatch photo.
- Receive and log. Match the alias across courier label, inner carton and certificate; inspect seals and cold packs; photograph everything before storage.
- Test. Send vials to your own lab for RP-HPLC purity, MS identity and net content, against the criteria in the purchase order.
- Compare and decide. A match within your criteria qualifies the lot and the supplier; a mismatch goes back to the supplier with the chromatogram attached.
- Scale. Only then move to a production batch, typically 14–21 days, to private-label OEM from 50 kits (500 vials), or to bulk powder from 5 g, shipped cold-chain. Repeat the record check and the alias chain for every production lot; qualification is of the supplier, acceptance is per lot.
The whole routine is a few emails, one WhatsApp message, one sample order and one lab invoice. Against a production batch that cannot be used, it is the least expensive quality step in GLP-1 procurement, and the one a clone site has no way around.
Sources and verification
- Pepti public COA library — 76 entries as checked 2026-10-19; record format and lot-alias pattern
- Batch record PEP260819-RT20 (retatrutide 20 mg) — HPLC 99.26%; manufactured 2026-08-19, tested 2026-08-22
- Batch record PEP260722-TR30 (tirzepatide 30 mg) — HPLC 99.7%; manufactured 2026-07-22, tested 2026-07-29
- Batch record PEP260718-SM20 (semaglutide 20 mg) — HPLC 99.6%; manufactured 2026-07-18, tested 2026-07-28
- Janoshik Analytical report #210105 — Retatrutide 20 mg sample, 19.52 mg content, 99.837% purity, analyzed 2026-10-07; sample-specific result
- PubChem CID 171934787 (retatrutide) — Formula C221H342N46O68, computed molecular weight 4731 g/mol
- PubChem CID 166567236 (tirzepatide) — Formula C225H348N48O68, computed molecular weight 4813 g/mol
- PubChem CID 56843331 (semaglutide) — Formula C187H291N45O59, computed molecular weight 4114 g/mol